Great Point Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-86,667
| Closed | -$16M | – | 48 |
|
|
2021
Q3 | $16M | Sell |
86,667
-89,739
| -51% | -$16.6M | 3.72% | 8 |
|
|
2021
Q2 | $31.6M | Buy |
176,406
+20,000
| +13% | +$3.59M | 6.64% | 4 |
|
|
2021
Q1 | $26.2M | Buy |
156,406
+6,406
| +4% | +$1.07M | 5.41% | 7 |
|
|
2020
Q4 | $22.8M | Sell |
150,000
-490,773
| -77% | -$74.5M | 3.7% | 13 |
|
|
2020
Q3 | $64.7M | Buy |
640,773
+20,773
| +3% | +$2.1M | 5.82% | 6 |
|
|
2020
Q2 | $75M | Buy |
620,000
+63,748
| +11% | +$7.71M | 6% | 7 |
|
|
2020
Q1 | $52.7M | Buy |
556,252
+15,073
| +3% | +$1.43M | 5.51% | 6 |
|
|
2019
Q4 | $47.7M | Buy |
541,179
+71,179
| +15% | +$6.27M | 4.15% | 11 |
|
|
2019
Q3 | $37.5M | Buy |
+470,000
| New | +$37.5M | 3.44% | 11 |
|
|
2019
Q2 | – | Sell |
-379,832
| Closed | -$44.6M | – | 35 |
|
|
2019
Q1 | $44.6M | Buy |
379,832
+29,032
| +8% | +$3.41M | 4.41% | 10 |
|
|
2018
Q4 | $38.2M | Buy |
350,800
+50,800
| +17% | +$5.53M | 4.83% | 8 |
|
|
2018
Q3 | $38.4M | Buy |
300,000
+130,361
| +77% | +$16.7M | 5.98% | 5 |
|
|
2018
Q2 | $19.2M | Buy |
+169,639
| New | +$19.2M | 2.66% | 15 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 43 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 38 |
|